A Network Pharmacology Approach to Uncover the Potential Mechanism of Yinchensini Decoction
Open Access
- 1 January 2018
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 2178610
Abstract
Objective. To predict and explore the potential mechanism of Yinchensini decoction (YCSND) based on systemic pharmacology. Method. TCMSP database was searched for the active constituents and related target proteins of YCSND. Cytoscape 3.5.1 was used to construct the active ingredient‐target interaction of YCSND and network topology analysis, with STRING online database for protein‐protein interaction (PPI) network construction and analysis; and collection from the UniProt database of target protein gene name, with the DAVID database for the gene ontology (GO) functional analysis, KEGG pathway enrichment analysis mechanism and targets of YCSND. Results. The results indicate the core compounds of YCSND, namely, kaempferol, 7‐Methoxy‐2‐methyl isoflavone, and formononetin. And its core targets are prostaglandin G/H synthase 2, estrogen receptor, Calmodulin, heat shock protein HSP 90, etc. PPI network analysis shows that the key components of the active ingredients of YCSND are JUN, TP53, MARK1, RELA, MYC, and so on. The results of the GO analysis demonstrate that extracellular space, cytosol, and plasma membrane are the main cellular components of YCSND. Its molecular functions are mainly acting on enzyme binding, protein heterodimerization activity, and drug binding. The biological process of YCSND is focused on response to drug, positive regulation of transcription from RNA polymerase II promoter, the response to ethanol, etc. KEGG results suggest that the pathways, including pathways in cancer, hepatitis B, and pancreatic cancer, play a key role in YCSND. Conclusion. YCSND exerts its drug effect through various signaling pathways and acts on kinds of targets. By system pharmacology, the potential role of drugs and the mechanism of action can be well predicted.Keywords
Funding Information
- National Natural Science Foundation of China (81373686)
This publication has 33 references indexed in Scilit:
- miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesisMolecular Cancer, 2016
- Glycosmis pentaphylla (Retz.) DC arrests cell cycle and induces apoptosis via caspase-3/7 activation in breast cancer cellsJournal of Ethnopharmacology, 2015
- Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC/LC-MS based metabolomics and network pharmacology approachesMolecular BioSystems, 2014
- Role of Preferential Cyclooxygenase-2 Inhibition by Meloxicam in Ischemia/Reperfusion Injury of the Rat LiverEuropean Surgical Research, 2014
- Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancerMolecular Oncology, 2013
- PAX2 Protein Induces Expression of Cyclin D1 through Activating AP-1 Protein and Promotes Proliferation of Colon Cancer CellsJournal of Biological Chemistry, 2012
- Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinomaOncogenesis, 2012
- Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2008
- Significance and Therapeutic Potential of Prostaglandin E2 Receptor in Hepatic Ischemia/Reperfusion Injury in Mice *Hepatology, 2005
- Acute experimental pancreatitis and NF-κB/rel activationPancreatology, 2002